Pathogenic Wnt-beta catenin target genes in macrophages and fibrosis
Immune System | Rheumatology/Scleroderma
What is the purpose of this trial?
The purpose of this research study is to better understand the development of systemic sclerosis (SSc)/scleroderma-related lung fibrosis (scarring)/interstitial lung disease (ILD) and how the development of scleroderma lung disease might be associated with scleroderma skin and esophageal disease. Study procedures will include: screening form, blood collection, skin biopsy collection, suture removal, and bronchoscopy.
- Trial withNational Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)
- Start Date06/01/2019
- End Date12/31/2023
- Last Updated07/15/2021
- Study HIC#2000024862